>suramin
They're investigating the use of a drug that they don't understand to treat a condition that they don't understand, through the lens of one model that variously competes with or incompletely conforms to a myriad of other models of the condition.
In order to what? Nebulously "manage" a complex neurological difference that will always defy reversion to anything else?
It sounds like they want something that they can prescribe, period. And it sounds like it has the potential to further complicate already difficult lives.
Type 1 Autism may serve a general human gene pool function in terms of edge-dripping a specific intelligence trait into it (low probability of reproduction, protecting general social skill in the pool, but adding a divergent pattern solving skill at the edges).
While autism is difficult, I'm not sure that solving for it in the context of industrial medicine is wise. We don't want to solve for Nicola Tesla, for example.
Type 2 and 3 Autism could be genetically unsuccessful attempts at Type 1 autism development, to spitball. Assuming they are actually related, in most cases. Such management theoretically could be helpful here, but I think that these people deserve a lot better than injected parasite medicine with a lot of side effects. Besides, try getting an autistic child used to regular injections.
Though a low-side effect oral or transdermal medication that would, say, specifically enhance energy support to the Autistic PFC with few side effects could be game changing. Likely for many more conditions than autism.
Inventing such a medication that doesn't lead to a worse baseline would be critical and perhaps unlikely.
Then again its possible that the unique pattern solving ability of the Autistic mind is related to the relative lack of energy supply to an increased volume of PFC neurons; and the subsequent failure of inhibition. Possibly accounting for increased environmental information perception, at least in-part. Which may in turn be mirrored in expanded cognition involved in pattern identification.
The ideal, which again I think is unlikely, would be a PRN medication that could "quiet" the autistic mind via providing more energy to the PFC; while having no withdrawal semi-permanent side effects.